|Continue certolizumab [156]|Strong| |
|Continue infliximab, etanercept, adalimumab, golimumab [144, 147, 150, 153]|Conditional| |
|Stop when pregnancy confirmed: rituximab, belimumab, anakinra, abatacept, tocilizumab, secukinumab, ustekinumab [164, 169, 160, 173, 177, 181, 185]|Conditional| |
|Use rituximab for organ-or life-threatening disease during pregnancy [165]|Conditional| |
|No recommendations for tofacitinib, baricitinib, apremilast due to lack of data [189, 193, 197]| | |